FDA to Replace Animal Testing with AI-Based Studies and Other Methods

Source: United Press International - Health NewsThe U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and other drugs. The regulatory change is intended to improve drug safety and accelerate the evaluation process while reducing animal experimentation, lowering research and development costs, and cutting drug prices, the FDA announced Thursday.